1. Home
  2. EVGOW vs HUMAW Comparison

EVGOW vs HUMAW Comparison

Compare EVGOW & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EVgo Inc.

EVGOW

EVgo Inc.

N/A

Current Price

$0.09

Market Cap

0.0

ML Signal

N/A

Logo Humacyte Inc. Warrant

HUMAW

Humacyte Inc. Warrant

HOLD

Current Price

$0.15

Market Cap

0.0

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVGOW
HUMAW
Founded
2010
2004
Country
United States
United States
Employees
331
220
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EVGOW
HUMAW
Price
$0.09
$0.15
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
74.7K
14.2K
Earning Date
03-07-2025
03-21-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$239,306,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
73.08
N/A
52 Week Low
$0.12
$1.18
52 Week High
$1.99
$1.34

Technical Indicators

Market Signals
Indicator
EVGOW
HUMAW
Relative Strength Index (RSI) 32.21 44.95
Support Level $0.10 $0.11
Resistance Level $0.14 $0.15
Average True Range (ATR) 0.01 0.03
MACD 0.00 0.00
Stochastic Oscillator 5.21 91.78

Price Performance

Historical Comparison
EVGOW
HUMAW

About EVGOW EVgo Inc.

EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.

About HUMAW Humacyte Inc. Warrant

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: